Comparative evaluation of antihypertensive effects of Ramipril vs. Losartan in patients with uncomplicated stage-1 hypertension

Journal Title: Journal of Drug Discovery and Therapeutics - Year 2014, Vol 2, Issue 6

Abstract

Hypertension is responsible for high morbidity and mortality in cardiovascular diseases. As Ramipril and Losartan are important ones due to extensive use, fewer side effects, low cost & availability in market, study was aimed to evaluate antihypertensive effects, tolerability & compliances of Ramipril & Losartan in patients with uncomplicated stage-1 hypertension in suburban & rural population. A randomized, single blind, parallel & cross over study was conducted in Medicine OPD of a tertiary care hospital for period of 12 months. Patients of both sexes, aged 25-60 years, with uncomplicated stage-1 hypertension were included. Patients with hypertension were checked for systolic blood pressure (SBP) / diastolic blood pressure (DBP) in sitting posture. Patients were randomly selected into 2 groups: group-A received tab. Ramipril (5 mg/day) & group-B received tab. Losartan (50 mg/day) at start of treatment, followed by wash-out period & then Losartan was given to group-A & ramipril to group-B. Paired t test applied between groups.

Authors and Affiliations

Vivek Das| MD, Department of Pharmacology, Burdwan Medical College & Hospital, Burdwan, Kolkata, India, Tanima Saha*| MBBS, MD PGT, Department of Pharmacology, Burdwan Medical College & Hospital, Burdwan, Kolkata, India, Himangshu Mahato| MBBS, MD PGT, Department of Pharmacology, Burdwan Medical College & Hospital, Burdwan, Kolkata, India, Swati Bhattacharyya| Associate Professor, Department of Pharmacology, R.G.Kar Medical College & Hospital, Burdwan, Kolkata, India, Supreeti Biswas| Professor & HOD, Department of Pharmacology, Burdwan Medical College & Hospital, Burdwan, Kolkata, India, M. R. Khandakar| Professor & HOD, Department of Medicine, COM & SDH, Burdwan, Kolkata, India

Keywords

Related Articles

MULTIFACETED USAGE OF HOLY BASIL

The unique chemistry of Tulsi is highly multifarious. Tulsi contains hundreds of beneficial compounds known as phyto-chemicals. Working together, these compounds possess strong antioxidant, antibacterial, antiviral, adap...

ARTEROLANE MALEATE AND PIPERAQUINE PHOSPHATE: A NEW OPTION IN THE TREATMENT OF PLASMODIUM FALCIPARUM MALARIA

Malaria is holoendemic in India, claiming thousands of deaths annually. Recent data suggests that the burden of malaria, the most significant parasitic disease in the world, is increasing. India’s expansive geography and...

GENE THERAPY AND CARCINOMA PROSTATE

Despite recent advances in early detection and treatment, prostate cancer is the most common cancer and the second leading cause of cancer-related deaths in developed countries. Prostate cancer patients having a limited...

Emerging drug discovery paradigm in non small cell lung cancer: pharmacophore modeling, atom-based 3D- QSAR and virtual screening of novel EGFR inhibitors

EGFR is a significant drug target approached in the domain of the wide prevailing cancer type, non- small cell lung cancer and search for its potent inhibitor is an emerging opportunity in cancer drug discovery. Computat...

Screening of peripheral neuropathy among diabetic patients in urban health centre chidambaram

Background: The foot ulcers among diabetic patients are mostly neuropathic origin and therefore eminently preventable. Sensory neuropathy increases the risk of foot ulcerations by seven folds and peripheral arterial dise...

Download PDF file
  • EP ID EP1483
  • DOI -
  • Views 501
  • Downloads 25

How To Cite

Vivek Das, Tanima Saha*, Himangshu Mahato, Swati Bhattacharyya, Supreeti Biswas, M. R. Khandakar (2014). Comparative evaluation of antihypertensive effects of Ramipril vs. Losartan in patients with uncomplicated stage-1 hypertension. Journal of Drug Discovery and Therapeutics, 2(6), 34-40. https://europub.co.uk./articles/-A-1483